BRAIDWELL LP

Position in ARGX — Argenx SE

CIK 1920938 STAMFORD, CT

Position in ARGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$62,026,704

+$35,951,368 QoQ

Shares Held

84,939

+173.9% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

2.36%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRAIDWELL LP holds $1,648,117,197 across 48 Biotechnology names. ARGX ranks #9 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAI	Caris Life Sciences, Inc.	8,009,447	$143,208,912
2	CNTA	Centessa Pharmaceuticals plc	1,986,768	$78,914,424
3	XENE	Xenon Pharmaceuticals Inc.	1,338,452	$77,830,983
4	DNTH	Dianthus Therapeutics, Inc. /DE/	899,364	$75,474,626
5	EWTX	Edgewise Therapeutics, Inc.	2,347,583	$73,948,864
6	NUVL	Nuvalent, Inc.	700,429	$71,758,951
7	KOD	Kodiak Sciences Inc.	1,818,665	$69,327,509
8	CGON	CG Oncology, Inc.	984,783	$66,650,113

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$62,026,704	84,939	+173.9%	Shares	Sole	2026-05-15
2025-12-31	$26,075,336	31,007	-59.3%	Shares	Sole	2026-02-17
2025-09-30	$56,121,677	76,091	-60.9%	Shares	Sole	2025-11-14
2025-06-30	$107,207,329	194,491	+20.9%	Shares	Sole	2025-08-14
2025-03-31	$95,200,893	160,849	+99.2%	Shares	Sole	2025-05-15
2024-12-31	$49,671,090	80,766	-16.5%	Shares	Sole	2025-02-14
2024-09-30	$52,432,145	96,724	-42.1%	Shares	Sole	2024-11-14
2024-06-30	$71,783,996	166,924	-24.1%	Shares	Sole	2024-08-14
2024-03-31	$86,549,105	219,824	+43.5%	Shares	Sole	2024-05-15
2023-12-31	$58,283,397	153,204	+522.8%	Shares	Sole	2024-02-14
2023-03-31	$9,165,468	24,600	-50.0%	Shares	Sole	2023-05-15
2022-12-31	$18,638,436	49,200	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.